Control Bionics Limited (ASX: CBL)
Australia
· Delayed Price · Currency is AUD 0.0580
0.00 (0.00%)
Dec 20, 2024, 3:23 PM AEST
Control Bionics Revenue
In the fiscal year ending June 30, 2024, Control Bionics had annual revenue of 5.35M AUD, down -5.17%. Control Bionics had revenue of 2.39M in the half year ending June 30, 2024, with 16.51% growth.
Revenue
5.35M
Revenue Growth
-5.17%
P/S Ratio
1.73
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.36M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.18B |
| ResMed Inc. | 6.93B |
| Pro Medicus Limited | 161.50M |
| Fisher & Paykel Healthcare Corporation Limited | 1.74B |
| Cochlear Limited | 2.24B |
| Sonic Healthcare Limited | 8.97B |
| Telix Pharmaceuticals Limited | 645.68M |
| Ramsay Health Care Limited | 16.66B |